Skip to main content

Table 1 Clinical characteristics of the SLE patients at the time point of blood sampling

From: Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus

Characteristics

SLE (n= 63)

Control (n= 33)

Age, median (range), years

42 (19 to 81)

45 (24 to 79)

Female, %

94

85

Male, %

6

15

Disease duration, median (range), years

8 (0 to 45)

-

SLEDAI score, median (range)

2 (0 to 18)

-

Seizure

0

-

Psychosis

0

-

Organic brain syndrome

0

-

Visual disturbance

1

-

Cranial nerve disorder

1

-

Lupus headache

0

-

Cerebrovascular accident

0

-

Vasculitis

3

-

Arthritis

8

-

Myositis

1

-

Kidney involvement (urinary cast, hematuria, proteinuria or pyuria)

14

-

Mucocutaneous activity (rash, alopecia or mucosal ulcers)

12

-

Pleurisy

0

-

Pericarditis

0

-

Low complement (C3 or C4)

14

-

Anti-DNA antibodies

14

-

Fever

2

-

Thrombocytopenia

1

-

Leukopenia

2

-

  1. Items included in SLE disease activity (SLEDAI) are shown.